Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Pharmaceutical giant AstraZeneca, whose China president is under investigation, was previously investigated for medical insurance fraud cases involving cancer medication sales, according to new Chinese media reports. The news comes after the British-Swedish company announced on its official website last week that its China chief Leon Wang was cooperating “with an ongoing investigation”, and its…

Read More